1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Noncoding RNAs Offer Huge Therapeutic and Diagnostic Potential

As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention.

 
 
Nucleic Acid Therapeutics
Nucleic Acid Therapeutics
PRLog - Feb. 14, 2013 - NEW ROCHELLE, N.Y. -- Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156, vcohn@liebertpub.com

Noncoding RNAs Offer Huge Therapeutic and Diagnostic Potential

New Rochelle, NY, February 14, 2013—As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention. Guest Editor Tom Cech, PhD and Executive Editor Fintan Steele, PhD explore the enormous potential value of this rapidly advancing research area in their Editorial " The (Noncoding) RNA World." (online.liebertpub.com/doi/full/10.1089/nat.2013.1501) The authors introduce a special research section on noncoding RNAs published in the current issue of Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers (www.liebertpub.com). The Editorial is available free on the Nucleic Acid Therapeutics website (www.liebertpub.com/nat).

Dr. Cech, a Howard Hughes Medical Institute investigator and the Director of The BioFrontiers Institute at the University of Colorado Boulder, notes in the Editorial that the special section on noncoding RNAs illustrates the exciting progress being made, particularly related to the potential for research advances to lead to the development of novel therapeutic and diagnostic interventions.

Yolanda Sánchez and Maite Huarte, University of Navarra, Pamplona, Spain, provide an overview of the role of long noncoding RNAs in various diseases. In "Long Non-Coding RNAs: Challenges for Diagnosis and Therapies," (online.liebertpub.com/doi/full/10.1089/nat.2012.0414) the authors also discuss the potential for targeting these RNAs for therapeutic and diagnostic applications. Maitri Shah and George Calin, The University of Texas MD Anderson Cancer Center, Houston, TX, explore the emerging concept that noncoding microRNAs in the circulation might function as hormones. What role these microRNAs might play in disease is also examined in "The Mix of Two Worlds: Non-Coding RNAs and Hormones." (online.liebertpub.com/doi/full/10.1089/nat.2012.0375) Marc Weinberg and Kevin Morris, The Scripps Research Institute, La Jolla, CA, describe current understanding of the regulatory function of long noncoding RNAs and how it might be used to create an entirely new area of pharmacology in "Long Non-Coding RNA Targeting and Transcriptional De-Repression." (online.liebertpub.com/doi/full/10.1089/nat.2012.0412)

“The astoundingly diverse roles of noncoding RNAs across many areas of biology and disease are among the most exciting areas of current research," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. “It is increasingly clear that as our knowledge of these molecules improves, so will potential therapeutic applications that take advantage of their unique biological properties.”

Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).

About the Journal
Nucleic Acid Therapeutics
is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the Official Journal of the Oligonucleotide Therapeutics Society (http://www.oligotherapeutics.org). Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website (www.liebertpub.com/nat).

About the Publisher
Mary Ann Liebert, Inc. publishers
is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy and Human Gene Therapy Methods, Genetic Testing and Molecular Biomarkers, ASSAY and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. publishers website (www.liebertpub.com).

Photo:
http://www.prlog.org/12080170/1

--- End ---

Click to Share

Contact Email:
***@liebertpub.com Email Verified
Source:Mary Ann Liebert, Inc., publishers
Phone:914-740-2100
Zip:10801
Location:New Rochelle - New York - United States
Industry:Biotech, Medical
Tags:rna, nucleic acid therapeutics, Fintan Steele, noncoding RNA
Shortcut:prlog.org/12080170
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share